Jason Powell to Enzyme Inhibitors
This is a "connection" page, showing publications Jason Powell has written about Enzyme Inhibitors.
Connection Strength
0.291
-
Wallington-Beddoe CT, Xie V, Tong D, Powell JA, Lewis AC, Davies L, Pitson SM, Bradstock KF, Bendall LJ. Identification of sphingosine kinase 1 as a therapeutic target in B-lineage acute lymphoblastic leukaemia. Br J Haematol. 2019 02; 184(3):443-447.
Score: 0.144
-
Pitman MR, Powell JA, Coolen C, Moretti PA, Zebol JR, Pham DH, Finnie JW, Don AS, Ebert LM, Bonder CS, Gliddon BL, Pitson SM. A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties. Oncotarget. 2015 Mar 30; 6(9):7065-83.
Score: 0.119
-
Wallington-Beddoe CT, Powell JA, Tong D, Pitson SM, Bradstock KF, Bendall LJ. Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression. Cancer Res. 2014 May 15; 74(10):2803-15.
Score: 0.028